BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34933376)

  • 1. Management of Vascular Thrombosis in Patients with Thrombocytopenia.
    Voigtlaender M; Langer F
    Hamostaseologie; 2022 Feb; 42(1):19-28. PubMed ID: 34933376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Linkins LA; Dans AL; Moores LK; Bona R; Davidson BL; Schulman S; Crowther M
    Chest; 2012 Feb; 141(2 Suppl):e495S-e530S. PubMed ID: 22315270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia and thrombosis.
    Ananthasubramaniam K; Shurafa M; Prasad A
    Prog Cardiovasc Dis; 2000; 42(4):247-60. PubMed ID: 10661778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia. Diagnosis, natural history, and treatment options.
    Kelton JG; Warkentin TE
    Postgrad Med; 1998 Feb; 103(2):169-71, 175-8. PubMed ID: 9479314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years.
    Tufano A; Brenner B
    Semin Thromb Hemost; 2024 Feb; 50(1):96-103. PubMed ID: 37201536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.
    Alving BM; Krishnamurti C
    Semin Thromb Hemost; 1997; 23(6):569-74. PubMed ID: 9469632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstacles in the diagnostics and therapy of heparin-induced thrombocytopenia.
    Antonijević NM; Radovanović N; Obradović S; Vucelić D; Stojanović B; Miković D; Kovac M; Kocica T; Tadić S; Antonijević I; Drasković S; Djordjević V; Calija B; Perunicić J; Vasiljević Z
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():69-73. PubMed ID: 20229687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of acquired thrombophilic disorders in 2011: focus on heparin-induced thrombocytopenia, antiphospholipid syndrome, myeloproliferative neoplasms and paroxysmal nocturnal hemoglobinuria.
    Emadi A; Streiff M
    Arch Iran Med; 2011 Nov; 14(6):401-11. PubMed ID: 22039845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer, thrombosis and heparin-induced thrombocytopenia.
    Prandoni P; Falanga A; Piccioli A
    Thromb Res; 2007; 120 Suppl 2():S137-40. PubMed ID: 18023709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
    Castelli R; Cassinerio E; Cappellini MD; Porro F; Graziadei G; Fabris F
    Cardiovasc Hematol Disord Drug Targets; 2007 Sep; 7(3):153-62. PubMed ID: 17896955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin-induced thrombocytopenia: implictions for cardiologist].
    Mattioli AV
    G Ital Cardiol (Rome); 2006 Oct; 7(10):675-83. PubMed ID: 17171989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Perini E; Penholati RR; Carvalho MG
    Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia.
    Arepally GM; Ortel TL
    Annu Rev Med; 2010; 61():77-90. PubMed ID: 20059332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiology for the primary care provider: heparin-induced thrombocytopenia.
    Benton RE; Gersh BJ
    South Med J; 1998 Feb; 91(2):133-7. PubMed ID: 9496863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin-induced thrombocytopenia and thrombosis. Thrombosis as an early cardinal symptom of heparin allergy].
    Folwaczny EK; Stürmer KM
    Chirurg; 2002 Dec; 73(12):1197-203. PubMed ID: 12491049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.